Power of the two one-sided tests procedure in bioequivalence
The power of the two one-sided tests procedure for testing bioequivalence is derived from the bivariate noncentral tdistribution. Power curves are shown and their use in planning bioequivalence experiments discussed. Sample sizes computed in the usual manner from an analysis of variance are shown to be too small to assure a declaration of bioequivalence except under favorable conditions.
Key wordsbioequivalence hypothesis testing power sample size
Unable to display preview. Download preview PDF.
- 1.Bioequivalence Task Force. Report on recommendations from the bioequivalence hearing conducted by the Food and Drug Administration, September 29–October 1, 1986.Google Scholar
- 4.R. E. Odeh and D. B. Owen.Tables for Normal Tolerance Limits, Sampling Plans, and Screening, Marcel Dekker, New York, 1980.Google Scholar
- 6.SAS.SAS User's Guide: Basics, Version 5, SAS Institute, Cary, NC, 1985.Google Scholar
- 7.W. J. Westlake. The design and analysis of comparative blood-level trials. In J. Swarbrick (ed.),Current Concepts in the Pharmaceutical Sciences, Dosage Form Design and Bioavailability, Lea & Febiger, Philadelphia, 1973, pp. 149–179.Google Scholar